Get the Stockscreener App
18.08
1.15%
-0.21
After Hours:
17.83
-0.25
-1.38%
Optimizerx Corp stock is traded at $18.08, with a volume of 322.10K.
It is down -1.15% in the last 24 hours and up +2.96% over the past month.
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
See More
Previous Close:
$18.29
Open:
$18.91
24h Volume:
322.10K
Relative Volume:
0.92
Market Cap:
$335.66M
Revenue:
$62.81M
Net Income/Loss:
$-13.75M
P/E Ratio:
-22.60
EPS:
-0.8
Net Cash Flow:
$153.00K
1W Performance:
-3.57%
1M Performance:
+2.96%
6M Performance:
+121.57%
1Y Performance:
+175.19%
1-Day Range:
$18.04
$19.77
1-Week Range:
$17.45
$19.77
52-Week Range:
$3.78
$20.70
Optimizerx Corp Stock (OPRX) Company Profile
Name
Optimizerx Corp
Sector
Industry
Phone
248-651-6558
Address
260 CHARLES STREET, WALTHAM, MI
Compare OPRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
18.08 | 339.55M | 62.81M | -13.75M | 153.00K | -0.80 |
|
VEEV
Veeva Systems Inc
|
286.59 | 48.92B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
96.39 | 17.25B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
65.61 | 13.59B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
90.52 | 7.99B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.70 | 7.14B | 906.14M | -52.62M | 89.62M | -0.3621 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Jul-25-24 | Resumed | B. Riley Securities | Buy |
| Apr-04-24 | Initiated | JMP Securities | Mkt Outperform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Feb-02-23 | Resumed | B. Riley Securities | Buy |
| Nov-01-22 | Initiated | Stifel | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Outperform |
| Oct-18-21 | Resumed | B. Riley Securities | Buy |
| Apr-13-21 | Initiated | RBC Capital Mkts | Outperform |
| Jan-03-19 | Initiated | William Blair | Outperform |
View All
Optimizerx Corp Stock (OPRX) Latest News
Does OptimizeRx Corporation qualify in momentum factor screening2025 Market WrapUp & Scalable Portfolio Growth Ideas - newser.com
What does recent volatility data suggest for OptimizeRx CorporationJuly 2025 News Drivers & Daily Technical Forecast Reports - newser.com
Real time social sentiment graph for OptimizeRx CorporationGold Moves & Safe Capital Investment Plans - newser.com
How to integrate OptimizeRx Corporation into portfolio analysis toolsQuarterly Growth Report & Detailed Earnings Play Alerts - newser.com
OptimizeRX price target raised to $23 from $20 at Citizens - Investing.com
Does OptimizeRx Corporation show high probability of reboundAnalyst Upgrade & Daily Profit Focused Stock Screening - newser.com
Using Bollinger Bands to evaluate OptimizeRx CorporationJuly 2025 Sector Moves & Reliable Entry Point Alerts - newser.com
Pattern recognition hints at OptimizeRx Corporation upsideMarket Performance Recap & Real-Time Volume Surge Alerts - newser.com
What drives OptimizeRx Corporation stock priceStock Watchlist Updates & Small Investment Big Gains - earlytimes.in
Analysts Set OptimizeRx Corp. (NASDAQ:OPRX) Price Target at $11.81 - Defense World
OptimizeRx: How The Stock Is Changing Pharma Marketing (NASDAQ:OPRX) - Seeking Alpha
OptimizeRx CEO Silvestro sells $30k in shares - Investing.com
Is OptimizeRx (NASDAQ:OPRX) Using Too Much Debt? - simplywall.st
Insider Stock Buying Of OptimizeRx Delivers Return On US$2.54m Investment - 富途牛牛
OptimizeRx Corp. Hits New 52-Week High of $20.66, Up 79.82% - Markets Mojo
OptimizeRx Corp. (OPRX) is a Great Momentum Stock: Should You Buy? - sharewise.com
Head-To-Head Survey: OptimizeRx (NASDAQ:OPRX) vs. SAP (NYSE:SAP) - Defense World
OptimizeRx Bets on AI and Workflow IntegrationWill This Pay Off? - Zacks Investment Research
Can volume confirm reversal in OptimizeRx CorporationQuarterly Portfolio Report & Breakout Confirmation Trade Signals - newser.com
OptimizeRx Corp. Hits New 52-Week High of $19.47, Up 67.19% Year-Over-Year - Markets Mojo
Institutional investors have a lot riding on OptimizeRx Corporation (NASDAQ:OPRX) with 65% ownership - Yahoo Finance
OptimizeRx Corporation's (NASDAQ:OPRX) Shift From Loss To Profit - simplywall.st
Signal strength of OptimizeRx Corporation stock in tech scannersWeekly Profit Report & Verified Stock Trade Ideas - newser.com
Visual trend scoring systems applied to OptimizeRx CorporationJuly 2025 Sector Moves & Consistent Profit Trade Alerts - newser.com
Exit strategy if you’re trapped in OptimizeRx Corporation2025 Major Catalysts & Real-Time Volume Spike Alerts - newser.com
Aug Spikes: Should you buy the dip on OptimizeRx CorporationWeekly Volume Report & AI Driven Stock Reports - خودرو بانک
Volatility clustering patterns for OptimizeRx CorporationWeekly Stock Recap & Reliable Intraday Trade Alerts - newser.com
Growth Value: Can OptimizeRx Corporation ride the EV waveEarnings Summary Report & Consistent Return Investment Signals - خودرو بانک
Short Squeeze: Does OptimizeRx Corporation have strong fundamentals2025 Top Decliners & High Accuracy Investment Entry Signals - khodrobank.com
Is OptimizeRx Corporation trending in predictive chart models2025 Institutional Moves & Weekly Watchlist for Consistent Profits - newser.com
Risk vs reward if holding onto OptimizeRx CorporationGap Up & Smart Investment Allocation Insights - newser.com
Will OptimizeRx Corporation outperform the marketInsider Selling & Real-Time Stock Movement Alerts - newser.com
Aug Drivers: Should value investors consider OptimizeRx Corporation2025 Volatility Report & Consistent Growth Equity Picks - خودرو بانک
Will OptimizeRx Corporation stock go up soonBond Market & Capital Efficient Trading Techniques - newser.com
Can OptimizeRx Corporation deliver consistent EPS growthJuly 2025 Closing Moves & High Accuracy Buy Signal Tips - khodrobank.com
Smart Money: Is OptimizeRx Corporation stock trending bullishWeekly Earnings Recap & Stock Timing and Entry Methods - خودرو بانک
How to interpret RSI for OptimizeRx Corporation stockShare Buyback & Verified Trade Idea Suggestions - newser.com
Investment Report: Is OptimizeRx Corporation stock a smart retirement pickMarket Growth Summary & AI Enhanced Market Trend Forecasts - خودرو بانک
Published on: 2025-09-17 15:37:17 - خودرو بانک
Aug Setups: Is OptimizeRx Corporation stock a value trapWeekly Trend Recap & Consistent Income Trade Ideas - خودرو بانک
What candlestick patterns are forming on OptimizeRx Corporation2025 Technical Patterns & High Accuracy Swing Entry Alerts - newser.com
OptimizeRx (NASDAQ:OPRX) Director Patrick D. Spangler Sells 11,120 Shares - MarketBeat
OptimizeRx Earnings Call: Strong Growth and Positive Outlook - MSN
OptimizeRx Corp. (NASDAQ:OPRX) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
OptimizeRx Corp. (NASDAQ:OPRX) Receives $11.81 Consensus PT from Analysts - MarketBeat
Optimizerx Corp Stock (OPRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Optimizerx Corp Stock (OPRX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Silvestro Stephen L | Chief Executive Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
6,649 |
0 |
190,536 |
| Silvestro Stephen L | Chief Executive Officer |
Oct 03 '25 |
Sale |
18.75 |
1,620 |
30,375 |
188,916 |
| Stelmakh Edward | Chief Finance & Strat Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
16,623 |
0 |
127,387 |
| Besch Doug | Chief Product & Tech Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
3,325 |
0 |
70,555 |
| Spangler Patrick D | Director |
Aug 28 '25 |
Sale |
17.49 |
11,120 |
194,489 |
44,215 |
8.35%
1.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):